Boston Partners Makes New Investment in Addus HomeCare Co. (NASDAQ:ADUS)

Boston Partners purchased a new stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 120,329 shares of the company’s stock, valued at approximately $12,215,000.

A number of other hedge funds have also bought and sold shares of the business. Principal Securities Inc. purchased a new position in shares of Addus HomeCare in the fourth quarter valued at $26,000. GAMMA Investing LLC purchased a new stake in Addus HomeCare in the 4th quarter worth approximately $34,000. EntryPoint Capital LLC bought a new position in Addus HomeCare in the 1st quarter valued at $44,000. Assetmark Inc. grew its position in shares of Addus HomeCare by 33.3% during the 4th quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock valued at $165,000 after purchasing an additional 443 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. bought a new position in shares of Addus HomeCare in the fourth quarter worth $214,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the company’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,186,500.21. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 4.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ADUS has been the subject of several research analyst reports. Stephens lifted their price objective on Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a research note on Friday, May 31st. Barclays downgraded shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 target price on the stock. in a research note on Tuesday, April 23rd. TD Cowen lifted their target price on shares of Addus HomeCare from $119.00 to $128.00 and gave the company a “buy” rating in a research report on Tuesday, June 18th. Oppenheimer raised their price objective on shares of Addus HomeCare from $118.00 to $130.00 and gave the company an “outperform” rating in a research report on Friday, June 7th. Finally, StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. One investment analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $117.86.

Addus HomeCare Trading Down 1.3 %

Shares of NASDAQ ADUS traded down $1.63 during mid-day trading on Friday, hitting $120.32. The stock had a trading volume of 111,753 shares, compared to its average volume of 154,031. The business has a 50 day moving average price of $118.06 and a two-hundred day moving average price of $104.65. Addus HomeCare Co. has a 1 year low of $78.35 and a 1 year high of $125.24. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.35 and a current ratio of 1.35. The firm has a market cap of $2.18 billion, a P/E ratio of 29.86, a price-to-earnings-growth ratio of 2.35 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.24. The company had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. Addus HomeCare’s quarterly revenue was up 11.6% on a year-over-year basis. During the same period last year, the firm earned $0.84 earnings per share. On average, equities analysts anticipate that Addus HomeCare Co. will post 4.36 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.